| For: | Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397 [PMID: 36158924 DOI: 10.4254/wjh.v14.i7.1382] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i7/1382.htm |
| Number | Citing Articles |
| 1 |
Elena Cristina Rusu, Helena Clavero-Mestres, Mario Sánchez-Álvarez, Marina Veciana-Molins, Laia Bertran, Pablo Monfort-Lanzas, Carmen Aguilar, Javier Camaron, Teresa Auguet. Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery. Computers in Biology and Medicine 2025; 191 doi: 10.1016/j.compbiomed.2025.110170
|
| 2 |
Bingbing Wang, Siyi Wu, Zuxiong Huang, Wenhui Zhang, Han Sun, Lingling Zhu, Yanxin Huang, Aili Zhao, Wenxiang Wang. Enteromorpha Polysaccharides Alleviate High‐Fat Diet‐Induced Glucolipid Metabolism Disorders via the K18‐Mediated IRS‐1/PI3K/AKT/GSK3β Pathway. Journal of Food Science 2025; 90(11) doi: 10.1111/1750-3841.70713
|
| 3 |
Mohammadreza Gholamrezapour, Raziyeh Taghizadeh Ghavamabadi, Mohammad Mohsen Taghavi, Samereh Dehghani Soltani, Ahmad Shabanizadeh, Reza Vazirinejad, Zahra Taghipour. Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells. Journal of Molecular Histology 2025; 56(1) doi: 10.1007/s10735-024-10313-2
|
| 4 |
Natacha Cerisier, Bryan Dafniet, Anne Badel, Olivier Taboureau. Linking chemicals, genes and morphological perturbations to diseases. Toxicology and Applied Pharmacology 2023; 461 doi: 10.1016/j.taap.2023.116407
|
| 5 |
Yang En‐Xi Chen, Amir Amir Samih Sadek, Fang Li, Guo‐Zheng Zhang, Ning‐Lin Wu, Xiao‐Dong Sun, Mohamed El‐Kassas, Ahmed Ihab Abdelaziz, Yuan‐Yuan Zhang, Injie Omar Fawzy. Sexual Dimorphism in Metabolic Dysfunction‐Associated Steatotic Liver Disease: The Emerging Role of Non‐Coding RNAs. Comprehensive Physiology 2026; 16(3) doi: 10.1002/cph4.70156
|
| 6 |
Miao Zheng, Kai Huang, Yuanshi She, Jun Qian, Feng Zhang, Qiaocheng Zhai. Platelet-derived growth factor-BB (PDGF-BB): pathophysiological roles and therapeutic implications in aging-related diseases. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1926050
|
| 7 |
Aylin Acun, Letao Fan, Ruben Oganesyan, Korkut M. Uygun, Heidi Yeh, Martin L. Yarmush, Basak E. Uygun. Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte Culture. Advanced Healthcare Materials 2024; 13(13) doi: 10.1002/adhm.202302943
|
| 8 |
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 2023; 3(4) doi: 10.3390/livers3040045
|
| 9 |
Min Yin, Yan Zhang, Shanshan Liu, Xia Li. Chemokines and chemokine receptors in metabolic dysfunction-associated steatohepatitis: pathogenic mechanisms and clinical implications. Cellular & Molecular Biology Letters 2026; 31(1) doi: 10.1186/s11658-026-00921-z
|
| 10 |
Ruiyi Liu, Yan Sun, Dong Di, Xiyuan Zhang, Boran Zhu, Haoxin Wu.
PI3K/AKT/SERBP-1 pathway regulates
Alisma orientalis
beverage treatment of atherosclerosis in APOE
−/−
high-fat diet mice
. Pharmaceutical Biology 2023; 61(1) doi: 10.1080/13880209.2023.2168020
|
| 11 |
Jyoti Sharma, Priyankar Dey. Multiparametric and Pathomimetic In Vitro Platform Mimicking Human Hepatic Steatosis, Lipotoxicity, and Associated Metabolic Stress. Chemical Research in Toxicology 2026; 39(7) doi: 10.1021/acs.chemrestox.6c00049
|
| 12 |
Miguel D. Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda, Antoni Pons. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants 2023; 12(3) doi: 10.3390/antiox12030711
|
| 13 |
Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy. Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease. International Journal of Biological Macromolecules 2024; 282 doi: 10.1016/j.ijbiomac.2024.137235
|
| 14 |
Logan Dameris, Joshua Hartsell, Jessie Chappel, Xiaojing Liu, Michael Cowley. Cadmium exposure during adolescence and young adulthood induces signatures of metabolic dysfunction-associated steatotic liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-22462-9
|
| 15 |
Olga Y. Burenina, Roman K. Makarchenko, Maria P. Rubtsova, Olga A. Dontsova. Liver‐specific lncRNAs associated with liver cancers. FEBS Open Bio 2025; 15(9) doi: 10.1002/2211-5463.70079
|